Suppr超能文献

瑞芬太尼/组氨酸混合物对大鼠在选择程序下反应的影响。

Effects of remifentanil/histamine mixtures in rats responding under a choice procedure.

机构信息

Departments of Pharmacology.

Departments of Psychiatry, The Addiction Research, Treatment and Training Center of Excellence, University of Texas Health Science Center at San Antonio, Texas, USA.

出版信息

Behav Pharmacol. 2021 Jun 1;32(4):278-285. doi: 10.1097/FBP.0000000000000610.

Abstract

Intravenous drug self-administration remains the 'gold standard' for assessing abuse liability. Failure of a drug to maintain self-administration might indicate the absence of positive reinforcing effects but might also indicate the presence of aversive effects. Sensitivity to aversive and punishing effects of drugs (as well as nondrug stimuli) might collectively determine the likelihood of use, abuse and relapse. Using a choice procedure, this study compared the effects of remifentanil (mu opioid receptor agonist; 0.001-0.01 mg/kg/infusion) and histamine (H1-4 receptor agonist; 0.32-3.2 mg/kg/infusion), alone and in mixtures, to test the hypothesis that remifentanil/histamine mixtures are less reinforcing compared with remifentanil alone and less punishing compared with histamine alone. Male Sprague-Dawley rats (n = 10) chose between an intravenous infusion + a pellet and a pellet alone. Rats were indifferent to saline, chose remifentanil + a pellet over a pellet alone, and chose a pellet alone over histamine + a pellet. The effects of remifentanil/histamine mixtures generally were different from the constituent doses of histamine alone but not from remifentanil alone. A mixture containing 3.2 mg/kg/infusion histamine and either 0.001 or 0.0032 mg/kg/infusion remifentanil was not different from saline but was different from the effects of the constituent dose, insofar as choice increased compared with 3.2 mg/kg/infusion histamine alone and decreased compared with 0.001 or 0.0032 mg/kg/infusion remifentanil alone. Reinforcing doses of remifentanil combined with punishing doses of histamine can yield mixtures that are neither preferred nor avoided, offering 'proof-of-principle' for using drug mixtures to avoid adverse effects of opioid receptor agonists.

摘要

静脉药物自我给药仍然是评估滥用倾向的“金标准”。药物不能维持自我给药可能表明缺乏正强化作用,但也可能表明存在厌恶作用。对药物(以及非药物刺激)的厌恶和惩罚作用的敏感性可能共同决定使用、滥用和复发的可能性。本研究使用选择程序比较了瑞芬太尼(μ 阿片受体激动剂;0.001-0.01 mg/kg/输注)和组胺(H1-4 受体激动剂;0.32-3.2 mg/kg/输注)单独和混合物的作用,以检验瑞芬太尼/组胺混合物的假设比单独的瑞芬太尼的强化作用更小,比单独的组胺的惩罚作用更小。雄性 Sprague-Dawley 大鼠(n=10)在静脉输注+药丸和单独药丸之间进行选择。大鼠对生理盐水无反应,选择瑞芬太尼+药丸而不是单独的药丸,并且选择单独的药丸而不是组胺+药丸。瑞芬太尼/组胺混合物的作用通常与单独使用组胺的组成剂量不同,但与单独使用瑞芬太尼的作用不同。含有 3.2 mg/kg/输注组胺和 0.001 或 0.0032 mg/kg/输注瑞芬太尼的混合物与生理盐水没有区别,但与组成剂量的作用不同,因为与单独使用 3.2 mg/kg/输注组胺相比,选择增加,与单独使用 0.001 或 0.0032 mg/kg/输注瑞芬太尼相比,选择减少。瑞芬太尼的强化剂量与组胺的惩罚剂量相结合可以产生既不被偏好也不被回避的混合物,为使用药物混合物避免阿片受体激动剂的不良反应提供了“原理证明”。

相似文献

1
Effects of remifentanil/histamine mixtures in rats responding under a choice procedure.
Behav Pharmacol. 2021 Jun 1;32(4):278-285. doi: 10.1097/FBP.0000000000000610.
2
Punishment and reinforcement by opioid receptor agonists in a choice procedure in rats.
Behav Pharmacol. 2019 Jun;30(4):335-342. doi: 10.1097/FBP.0000000000000436.
3
Preference for an Opioid/Benzodiazepine Mixture over an Opioid Alone Using a Concurrent Choice Procedure in Rhesus Monkeys.
J Pharmacol Exp Ther. 2017 Jul;362(1):59-66. doi: 10.1124/jpet.117.240200. Epub 2017 Apr 24.
4
Reinforcing effects of opioid/cannabinoid mixtures in rhesus monkeys responding under a food/drug choice procedure.
Psychopharmacology (Berl). 2018 Aug;235(8):2357-2365. doi: 10.1007/s00213-018-4932-6. Epub 2018 Jun 3.
5
Effect of delay on self-administration of remifentanil under a drug versus drug choice procedure in rhesus monkeys.
J Pharmacol Exp Ther. 2013 Dec;347(3):557-63. doi: 10.1124/jpet.113.208355. Epub 2013 Sep 16.
6
Evaluation of potential punishing effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rhesus monkeys responding under a choice procedure.
Behav Pharmacol. 2024 Oct 1;35(7):378-385. doi: 10.1097/FBP.0000000000000787. Epub 2024 Jul 17.
7
Effects of the synthetic cannabinoid receptor agonist JWH-018 on abuse-related effects of opioids in rhesus monkeys.
Drug Alcohol Depend. 2019 Sep 1;202:33-38. doi: 10.1016/j.drugalcdep.2019.04.024. Epub 2019 Jun 29.
8
Interactions between opioids and cannabinoids: Economic demand for opioid/cannabinoid mixtures.
Drug Alcohol Depend. 2020 Jul 1;212:108043. doi: 10.1016/j.drugalcdep.2020.108043. Epub 2020 May 12.
9
Delay discounting of food and remifentanil in rhesus monkeys.
Psychopharmacology (Berl). 2013 Sep;229(2):323-30. doi: 10.1007/s00213-013-3121-x. Epub 2013 May 2.

引用本文的文献

1
Neural correlates of opioid-induced risk-taking behavior in the prelimbic prefrontal cortex.
J Neurosci. 2025 Mar 17;45(19). doi: 10.1523/JNEUROSCI.2422-24.2025.
2
Evaluation of potential punishing effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rhesus monkeys responding under a choice procedure.
Behav Pharmacol. 2024 Oct 1;35(7):378-385. doi: 10.1097/FBP.0000000000000787. Epub 2024 Jul 17.
3
Neural signatures of opioid-induced risk-taking behavior in the prelimbic prefrontal cortex.
bioRxiv. 2024 Dec 23:2024.02.05.578828. doi: 10.1101/2024.02.05.578828.
4
Neural circuits controlling choice behavior in opioid addiction.
Neuropharmacology. 2023 Mar 15;226:109407. doi: 10.1016/j.neuropharm.2022.109407. Epub 2022 Dec 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验